Registrations for the next session of the course will start in Jan, 2018

About Us

Established in 1927, FICCI is the largest and oldest apex business organisation in India. Its history is closely interwoven with India's struggle for independence, its industrialization, and its emergence as one of the most rapidly growing global economies. A non-government, not-for-profit organisation, FICCI is the voice of India's business and industry. From influencing policy to encouraging debate, engaging with policy makers and civil society, FICCI articulates the views and concerns...

  • About the Course

    The pharmaceutical industry always has unusual prominence in the debates about intellectual property rights. The pharma sector has served as the front line...

    Know More
  • Course Methodology

    The course is conducted in two stages: Stage 1: Study Material will be provided to Students along...

    Know More
  • Eligibility

    Law students desirous of specializing in IPR and Pharmaceutical R &D. Anybody from Science...

    Know More
  • Course Duration and Fees

    Course Duration: 3 Months a) For Students: Rs. 10500/- b) For Industry Professionals and others: Rs. 12500/- Payment...

    Know More
COURCES

Learn IP & Pharmaceutical R&D

News & Events

Aug 25

FICCI-IPO Joint IP Awareness

More
  • Jul 21

    FICCI Conference on Copyright and the Creative Economy

    More
  • Apr 28

    World IP Day 2017 "Innovation to Drive Business and Competitiveness"

    More
  • Jan 06

    Launch of FICCI-DIPP IPR Enforcement Toolkit for Police

    More

Subscribe

to our newsletter

WHAT IP EXPERTS HAVE TO SAY?

Ravi Bhola

Partner, K & S Partners | Intellectual Property Attorneys

FICCI online courses are helpful and comprehensive. The course content covers the basic to advanced concepts on IPR which are precise and easy to understand. The platform is user-friendly and interactive. In addition, live webinars with industry experts are particularly helpful for participants in learning the complex concepts on IPRs.

Vivek Dahiya

Principal Associate at Groverlaw & SBU Head at Sagacious Research Pvt. Ltd.

The courses offered by FICCI not only provide insights of each and every aspect of the topics besides the course materials are kept dynamic to suit constantly changing dynamics of the Intellectual Property domain, especially in India.

Pharma Industry – Innovators and Generics

Purpose of this section is to apprise about the pioneers in Pharmaceuticals and their history, their business schemes and their monetary integers. Lessons cover topics like stratification of drugs and codification of drugs patented after 01 January, 1995 [New Chemical Entities (NCE) and New Biological Entities (NBE)]. It also includes topics providing information based on distinction between Biosimilar and Generics, scathing interpretation of Bolar Exemption in Indian Patent Law, facet operating Pharma business and Article 41 and 51 (Suspension of Release by Customs Authorities) of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement. 

Legal and Regulatory Perspective

It provides lectures concerning various regulatory approvals (Indian as well as global) required by Pharma companies such as Drug Regulatory Affairs (DRA), Food Drug Administration (FDA) etc. This module also goes over the system of Patent Linkage in India, US and in other countries of the world. It teaches to generate solutions to global challenges (vaccines, drugs etc.) and to resolve National Biodiversity Authority (NBA) approval matters. It also assembles Bio piracy (Convention on Biological Diversity [CBD]), The Rio Earth Summit (1992), Nagoya Protocol on biodiversity which is negotiated in Japan (2010) and Traditional Knowledge Digital Library (TKDL) on a single platform.

Intellectual Property Laws

This section appraise the description of IP laws and post TRIPS IP environment), basics, filing & registration processes for all IP segments.  It also includes attributes of patents (drafting, searches, oppositions, infringement and commercialization) and patentability criteria. This module enlightens Patent ever-greening and design protection strategies globally (Drug price competition and Patent term restoration act) and Madrid and Central Drugs Standard Control Organization (Resources for unregistered names).

This section notifies about the basics of Competition Law and Indian Patent Act for pharmaceuticals, US and EU Patent Law including America Invents Act (AIA), Exclusive Marketing Rights, Data Exclusivity, Territorial rights and Nationality issues.

Purpose of this section is to provide inclusive knowledge of IP protection for Computer software and new CRI guidelines, Statutory exception, Copyright infringement and licensing (Agreements with Copyright Clearance Center and journal subscriptions). It facilitates teaching on Content sharing habits and challenges and copyright compliance. It enlightens about Package inserts/ Information leaflet for copyright and various case law studies. 

Pharmaceuticals and IP Laws

This module includes selected course lectures on Biopharmaceutical Intellectual Property Rights, their impression on R&D and associated challenges. It also includes citations to Competition Law and IP Law from Pharma industry and also explains about current scenario and future challenges in Pharma segment. This module also provides quality knowledge of Patent non-infringement, Pre-grant and post-grant oppositions and   Intellectual Property Appellate Board (IPAB) & S.64 Revocations in IPAB High Court and provides detailed information regarding Freedom-to-operate analysis and write-to-use opinions.

Exercise

This section is designed to make teachings regarding Specification and Claim Drafting assignments, Specimen Prior Art Search Applications and live case studies. Some of the lectures include Claim chart drafting, Patent searching and analytics aid and Patent Mapping. It also assists analyzing previous Examination papers of Patent Agent Exam conducted by the Indian Patent Office. A segment of this module also organizes Workshops on Filing and searching of Patents.